Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Depression in Acute Coronary Syndrome (ACS) Patients (TREATED-ACS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by University of Bologna.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Compagnia San Paolo
Information provided by:
University of Bologna
ClinicalTrials.gov Identifier:
NCT00998400
First received: October 19, 2009
Last updated: March 1, 2011
Last verified: September 2010

October 19, 2009
March 1, 2011
September 2010
October 2011   (final data collection date for primary outcome measure)
Depression and well-being improvements after Cognitive-behavioral Therapy and Well-Being Therapy assessed by changes in Clinical Interview for Depression, Symptom Questionnaire and Psychological Well-Being, compared to Clinical Management [ Time Frame: Within two years after the treatment ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00998400 on ClinicalTrials.gov Archive Site
Reduction of cardiovascular hospitalizations, revascularization, recurrent nonfatal myocardial infarction or cardiac mortality after CBT and WBT compared with CM [ Time Frame: Within two years after the treatment ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Treatment of Depression in Acute Coronary Syndrome (ACS) Patients
Cognitive-behavioral Treatment of Depression in Patients With Acute Coronary Syndrome

Emotional states of depression in association with ischemic heart diseases, such as myocardial infarction or unstable angina, are risk factors for subsequent cardiac events and mortality. However, the only psychological intervention trial attempting to reduce cardiac risk in depressed ACS patients showed that changes in depression did not translate into improved survival. Such intervention did not address issues such as lifestyle modification and improvement in psychological well-being, which were found to affect individual vulnerability to medical disease. Our research group has developed a well-being enhancing psychotherapeutic strategy, well-being therapy (WBT), which has been validated in a number of clinical trials. The aim of this project is to evaluate the efficacy of cognitive behavioral treatment (CBT) together with lifestyle modification and WBT in reducing cardiac risk in depressed and/or demoralized ACS patients compared to a standard clinical procedure of patients' management, the clinical management (CM). The same protocol will be carried out in two centres (Bologna and Torino). 100 patients after a first episode of myocardial infarction or unstable angina, meeting DSM-IV criteria for depressive disorders and DCPR criteria for demoralization will be randomized to one of two treatment groups: 1) CBT supplemented by lifestyle modification and WBT; 2) CM. In both groups, treatment will consist of twelve, 45-minute sessions once a week. A two-year follow-up will be performed. It is expected that psychological treatment may significantly decrease cardiac morbidity and mortality at follow-up compared to clinical management. The findings may entail considerable preventive implications and possible large reductions in health costs.

The same protocol will be carried out in the two participating centres (Maggiore Hospital in Bologna and San Giovanni Battista Hospital in Torino).

Participants will be patients recovering from a first episode of acute myocardial infarction or unstable angina. Myocardial infarction will be documented by cardiac symptoms (presence of acute chest, epigastric, neck, jaw, or arm pain or discomfort or pressure without apparent non- cardiac source) and signs (acute congestive heart failure or cardiogenic shock in the absence of non-CHD causes) associated with ECG findings (characteristic evolutionary ST-T changes or new Q waves) and/or cardiac biomarkers (blood measures of myocardial necrosis, specifically CK, CK-MB, CK-MBm, or troponin, cTn). Instable angina will be documented by cardiac symptoms (chest pain lasting less than 20 minutes) with likely ECG findings (ST-segment depression and abnormal T-wave) in absence of myocardial necrosis biomarkers.

Medically eligible patients involved in the study have to meet, when screened 30 days after their index event, the inclusion criteria

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Depression
Behavioral: CBT in combination with WBT and life style modification
CBT involves several essential features: identifying and correcting inaccurate thoughts associated with depressed feelings (cognitive restructuring); helping patients to engage more often in enjoyable activities (behavioral activation); enhancing problem-solving skills; providing instruction and guidance in specific strategies for solving problems. The techniques included in WBT may be used in overcoming impairments in environmental mastery, purpose in life, personal growth, autonomy, self-acceptance and positive relations with others. CM will consist of reviewing the patients' clinical status, and providing the patient with support and advice if necessary.
Other Name: Cognitive-behavioural therapies
  • No Intervention: Clinical Management
    Control group
  • Experimental: CBT + WBT
    Patients treated with Cognitive-Behavioral Therapy in combination with Well-Being Therapy and lifestyle modification
    Intervention: Behavioral: CBT in combination with WBT and life style modification
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
October 2013
October 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • a current diagnosis of at least one of the following: major or minor depression, dysthymia according to DSM-IV criteria, and demoralization according to DCPR criteria
  • Mini-Mental State Examination score higher than 24
  • written informed consent provided by the patient to participate

Exclusion Criteria:

  • history of bipolar disorder (DSM-IV criteria)
  • major depression with psychotic features
  • history of substance abuse or dependency during the previous 12 months
  • serious suicide risk
  • current use of antidepressants
  • current treatment with any form of psychotherapy
Both
Not Provided
No
Contact: Chiara Rafanelli, MD, Ph.D +39-051-2091847 chiara.rafanelli@unibo.it
Italy
 
NCT00998400
2008.1263
No
Chiara Rafanelli, Department of Psychology, University of Bologna
University of Bologna
Compagnia San Paolo
Principal Investigator: Chiara Rafanelli, MD, Ph.D Department of Psychology, University of Bologna
University of Bologna
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP